1. Spain Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Atrys Health SA

Atrys Health SA

BBME:ATRY
2.61
EUR
-0.05
(-1.88%)
192.45MMarket Cap
Mar 03Next Earn
Atrys Health SA
BME:ATRY
(Spanish Stock Exchange)

Recent

price

2.61

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
0.13
0.13
0.13
0.35
0.42
0.56
0.37
0.69
1.11
2.41
2.32
2.66
1.71
1.86
- -
Revenue per Share
0.08
0.04
0.04
0.16
0.01
0.03
- -
- -
-0.2
-0.46
-0.34
-0.6
-0.42
-1.32
- -
Basic EPS, GAAP
- -
- -
- -
- -
-0.22
-0.1
-0.16
-0.17
-0.24
-0.08
-0.45
-0.1
-0.13
-0.19
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
0.91
1.09
1.23
1.56
2.06
4.44
4.43
3.82
3.33
2
1.94
Book Value per Share
- -
- -
- -
- -
-0.53
0.11
-0.03
-0.59
-1.53
-1.86
-2.4
-2.12
-2.25
-0.74
-0.76
Tangible Book Value per Share
8
8
8
8
11
11
19
21
28
50
68
76
76
76
76
Basic Weighted Avg Shares
1
1
1
3
5
6
7
15
31
121
158
202
130
141
- -
Sales/Revenue/Turnover
7.37
-11.89
41.57
7.45
-2.13
11.95
9.68
8.02
-6.81
-10.24
-2.26
1.49
4.51
-4.07
- -
Operating Margin (%)
- -
- -
- -
- -
1
1
1
2
6
21
26
30
29
27
- -
Depreciation Expense
1
- -
- -
1
- -
- -
- -
- -
-6
-23
-23
-46
-32
-100
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
81.17
150.71
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
63.17
33.03
29.39
45.18
1.38
4.82
0.16
-0.71
-17.67
-19.22
-14.62
-22.62
-24.45
-71.13
- -
Profit Margin (%)
4
3
2
- -
2
8
10
8
16
30
1
-3
-11
-56
-63
Working Capital
10
11
11
12
1
10
15
30
60
137
210
190
196
34
32
LT Debt
- -
- -
- -
- -
10
19
26
40
71
273
336
290
253
152
147
Total Equity
- -
- -
- -
- -
- -
- -
0.37
-1.01
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
0.33
-1.07
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
2.02
0.05
-0.32
-9.97
-13.52
-7.6
-14.56
-11.7
-49.53
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
58
224
87
LT Borrowings
168
12
8
LT Finance Leases
25
22
24
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
76
76
76
Market Capitalization
194
222
192

Working Capital

EUR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
92
234
57
Cash, Cash Equivalents & STI
14
13
12
Accounts Receivable, Net
62
29
31
Inventories
2
2
2
Total Current Liabilities
111
290
120
Payables & Accruals
- -
- -
- -
ST Debt
58
224
87
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
47.77%
-40%
Free Cash Flow
- -
129.44%
38.8%
Net Income, GAAP
499.19%
120.2%
215.65%
Sales/Revenue/Turnover
64.39%
63.31%
8.49%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
130
2025
- -
- -
141
2026
- -
- -
- -

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.42
2025
- -
- -
-1.32
2026
- -
- -
- -

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Atrys Health SA operates as a global healthtech company specializing in precision medical diagnosis and treatment services, with a focus on telemedicine, cancer care, and preventive medicine. The company provides integrated diagnostics including structural and molecular pathology, genetics, nuclear medicine, teleradiology, telecardiology, teleoncology, teledermatology, teleophthalmology, and teleconsultations; oncology treatments encompassing chemotherapy, immunotherapy, advanced radiotherapy, brachytherapy, and teragnosis; preventive medicine plans for occupational risk prevention and employee health check-ups; and Smart Data technological databases for healthcare alongside research and development services. Atrys Health maintains diagnostic laboratories and translational research facilities in Barcelona and Granada, radiotherapy centers across Spain, Portugal, Switzerland, Mexico, Chile, Colombia, and Brazil, and over 400 healthcare centers in seven countries serving hospitals, insurers, corporates, and patients. Founded in 2007 and headquartered in Madrid, Spain, the company, formerly Althia Health SL until its rebranding in 2016, listed on BME Growth in 2016 and upgraded to the Main Market in 2022. Recent developments include the opening of the Institute of Advanced Oncology in Madrid, expansion of medical oncology centers in Mexico to five locations with two additional planned for late 2025, growth in genetics and pathology diagnostics, authorization for teragnosis services, and an agreement in November 2025 to sell its ASPY preventive business unit to Grupo Echevarne for 145 million euros to reduce net financial debt from 3.7x to around 1.0x EBITDA, yielding annual financial expense savings of 13 million euros.